Related Experiment Video
Updated: Mar 15, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
A Retrospective Observational Study to Assess Prescription Pattern in Patients with Type B Aortic Dissection and
Kuang-Ming Liao1, Chung-Yu Chen2, Shih-Han Wang3
1Department of Internal Medicine, Chi Mei Medical Center, Chiali, No. 606, Jialixing, Jiali District, Tainan 72263, Taiwan.
Insights
Medication effectiveness for Type B aortic dissection (TBAD) without surgery is unclear. This study found no significant difference in mortality or re-admission rates between different antihypertensive medication strategies in nonsurgical TBAD patients.
Area of Science:
- Cardiology
- Vascular Surgery
- Pharmacology
Background:
- Aortic dissection is a critical medical emergency.
- Optimal medical management for Type B aortic dissection (TBAD) without surgical intervention requires further clarification.
- Antihypertensive medication plays a crucial role in managing TBAD.
Purpose of the Study:
- To evaluate antihypertensive prescription patterns and their clinical effectiveness in patients with nonsurgical Type B aortic dissection (TBAD).
- To assess the association between different antihypertensive treatment strategies and outcomes in this patient population.
Main Methods:
- Retrospective cohort study of 106 patients with nonsurgical TBAD from January 2008 to June 2013.
- Analysis of hospital records for baseline information, antihypertensive prescribing patterns, and clinical outcomes.
- Cox proportional hazards model used to estimate outcomes, with primary endpoints of all-cause mortality and aortic dissection-related hospital admission.
Main Results:
- The most common comorbidities were hypertension, dyslipidemia, and diabetes mellitus.
- Over 80% of patients received dual or triple antihypertensive therapy.
- No significant difference in the primary outcomes (all-cause mortality, dissection re-admission) was observed between monotherapy and combination antihypertensive strategies.
Conclusions:
- Current antihypertensive medication regimens, including monotherapy and combination therapies, show no significant difference in clinical effectiveness for nonsurgical TBAD patients.
- Further research may be needed to optimize medical management strategies for this specific patient group.
Abstract:
Aortic dissection is a life-threatening condition. However, the use of medication to treat it remains unclear in our population, particularly in patients with a type B aortic dissection (TBAD) who do not receive surgery. This retrospective cohort study evaluated antihypertensive prescription patterns and outcomes in patients with nonsurgical TBAD. We reviewed the hospital records of patients with TBAD at a medical center in Taiwan from January 2008 to June 2013 to assess the baseline information, prescribing pattern, event rate, and clinical effectiveness of different antihypertensive treatment strategies. A Cox proportional hazards model was used to estimate outcomes in different antihypertensive strategies. The primary endpoints were all-cause mortality and hospital admission for an aortic dissection. We included 106 patients with a mean follow-up period of 2.75 years. The most common comorbidity was hypertension followed by dyslipidemia and diabetes mellitus. Study endpoints mostly occurred within 6 months after the index date. Over 80% of patients received dual or triple antihypertensive strategies. Patients treated with different treatment strategies did not have a significantly increased risk of a primary outcome compared with those treated with a monotherapy. We found no significant difference in the primary outcome following the use of different antihypertensive medication regimes.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Aortic Regurgitation I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
